Conclusion This study extends our understanding of peripregnancy TNFi treatment patterns in women with autoimmune diseases, illustrating an increasing trend of TNFi continuation in pregnancy across two administrative data sources in the United States. status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Revised 2026 Mar 18; Received 2025 Aug 12; Accepted 2026 Mar 27; Collection date 2026 May.
← all excerpts
Tumor Necrosis Factor Inhibitor Treatment and Persistence Patterns in the Peripregnancy Period in Patients With Inflammatory Autoimmune Diseases.
1
—
—